229 related articles for article (PubMed ID: 33226326)
1. Scleroderma renal crisis: Case reports and update on critical issues.
Zanatta E; Codullo V; Allanore Y
Eur J Rheumatol; 2021 Jul; 8(3):162-167. PubMed ID: 33226326
[TBL] [Abstract][Full Text] [Related]
2. Therapy of scleroderma renal crisis: State of the art.
Zanatta E; Polito P; Favaro M; Larosa M; Marson P; Cozzi F; Doria A
Autoimmun Rev; 2018 Sep; 17(9):882-889. PubMed ID: 30005860
[TBL] [Abstract][Full Text] [Related]
3. Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis.
Cole A; Ong VH; Denton CP
Clin Rev Allergy Immunol; 2023 Jun; 64(3):378-391. PubMed ID: 35648373
[TBL] [Abstract][Full Text] [Related]
4. Studying the Role of C5-Inhibition Therapy in Scleroderma Renal Crisis-Induced Thrombotic Microangiopathy - A Review of Literature.
Farrukh L; Steen VD; Shapiro L; Mehta S
Semin Arthritis Rheum; 2023 Dec; 63():152256. PubMed ID: 37689027
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis complicated with renal thrombotic microangiopathy: a case report and literature review.
Kong W; Wang Y; Wang H; Zhou Q; Chen J; Han F
BMC Nephrol; 2022 Jan; 23(1):22. PubMed ID: 35012481
[TBL] [Abstract][Full Text] [Related]
6. Classifications of scleroderma renal crisis and reconsideration of its pathophysiology.
Yamashita H; Kamei R; Kaneko H
Rheumatology (Oxford); 2019 Dec; 58(12):2099-2106. PubMed ID: 31566243
[TBL] [Abstract][Full Text] [Related]
7. Scleroderma renal crisis during intravenous cyclophosphamide pulse therapy for complicated interstitial lung disease was successfully treated with angiotensin converting enzyme inhibitor and plasma exchange.
Nagamura N; Kin S
Nagoya J Med Sci; 2016 Aug; 78(3):329-34. PubMed ID: 27578917
[TBL] [Abstract][Full Text] [Related]
8. Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication.
Moinzadeh P; Kuhr K; Siegert E; Blank N; Sunderkoetter C; Henes J; Krusche M; Schmalzing M; Worm M; Schmeiser T; Günther C; Aberer E; Susok L; Riemekasten G; Kreuter A; Zeidler G; Juche A; Hadjiski D; Müller-Ladner U; Gaebelein-Wissing N; Distler JHW; Sárdy M; Krieg T; Hunzelmann N
J Rheumatol; 2020 Feb; 47(2):241-248. PubMed ID: 30936287
[TBL] [Abstract][Full Text] [Related]
9. Scleroderma renal crisis and renal involvement in systemic sclerosis.
Woodworth TG; Suliman YA; Li W; Furst DE; Clements P
Nat Rev Nephrol; 2016 Nov; 12(11):678-691. PubMed ID: 27641135
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta-analysis.
Xiong A; Cao Y; Xiang Q; Song Z; Zhang Y; Zhou S; Qiang Y; Chen H; Hu Z; Cui H; Luo J; Wang Y; Yang Y; Yang M; Shuai S
J Clin Pharm Ther; 2022 Jun; 47(6):722-731. PubMed ID: 35233779
[TBL] [Abstract][Full Text] [Related]
11. Management review of scleroderma renal crisis: An update with practical pointers.
Foocharoen C; Tonsawan P; Pongkulkiat P; Anutrakulchai S; Mahakkanukrauh A; Suwannaroj S
Mod Rheumatol; 2023 Jan; 33(1):12-20. PubMed ID: 35349704
[TBL] [Abstract][Full Text] [Related]
12. Management of scleroderma renal crisis.
Nagaraja V
Curr Opin Rheumatol; 2019 May; 31(3):223-230. PubMed ID: 30870219
[TBL] [Abstract][Full Text] [Related]
13. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
Teixeira L; Mouthon L; Mahr A; Berezné A; Agard C; Mehrenberger M; Noël LH; Trolliet P; Frances C; Cabane J; Guillevin L;
Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
[TBL] [Abstract][Full Text] [Related]
14. Scleroderma renal crisis.
Bose N; Chiesa-Vottero A; Chatterjee S
Semin Arthritis Rheum; 2015 Jun; 44(6):687-94. PubMed ID: 25613774
[TBL] [Abstract][Full Text] [Related]
15. Scleroderma renal crisis.
Mouthon L; Bussone G; Berezné A; Noël LH; Guillevin L
J Rheumatol; 2014 Jun; 41(6):1040-8. PubMed ID: 24833760
[TBL] [Abstract][Full Text] [Related]
16. [13-year history of scleroderma complicated by renal crisis and thrombotic microangiopathy treated with plasma exchange: A case report].
Minami T; Akazawa M; Kanda E; Nonomura Y
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(2):116-20. PubMed ID: 26016639
[TBL] [Abstract][Full Text] [Related]
17. Scleroderma renal crisis is still a life-threatening syndrome.
Stratta P; Besso L; Ferrero S; Canavese C; Hollo S; Ottone S; Sandri L; Thea A; Mazzucco G
Ren Fail; 1996 Jul; 18(4):567-74. PubMed ID: 8875681
[TBL] [Abstract][Full Text] [Related]
18. Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus Infection.
Shimizu T; Iwamoto N; Okamoto M; Endo Y; Tsuji S; Takatani A; Igawa T; Umeda M; Fukui S; Sumiyoshi R; Kitamura M; Koga T; Kawashiri SY; Ichinose K; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
Intern Med; 2019 Feb; 58(3):441-445. PubMed ID: 30146597
[TBL] [Abstract][Full Text] [Related]
19. Systemic sclerosis medications and risk of scleroderma renal crisis.
Gordon SM; Hughes JB; Nee R; Stitt RS; Bailey WT; Little DJ; Edison JD; Olson SW
BMC Nephrol; 2019 Jul; 20(1):279. PubMed ID: 31345158
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.
Gordon SM; Stitt RS; Nee R; Bailey WT; Little DJ; Knight KR; Hughes JB; Edison JD; Olson SW
J Rheumatol; 2019 Jan; 46(1):85-92. PubMed ID: 30008456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
